Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ASPIRIN DL-LYSINE for Cardiovascular event prophylaxis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 653 adverse event reports in the FDA FAERS database where ASPIRIN DL-LYSINE was used for Cardiovascular event prophylaxis.

Most Reported Side Effects for ASPIRIN DL-LYSINE

Side Effect Reports % Deaths Hosp.
Acute kidney injury 658 9.9% 146 271
Anaemia 469 7.1% 34 356
Lactic acidosis 312 4.7% 113 30
Hyperkalaemia 246 3.7% 46 65
Interstitial lung disease 225 3.4% 25 153
Cerebral haemorrhage 219 3.3% 100 89
Fall 218 3.3% 79 140
Melaena 200 3.0% 31 152
Thrombocytopenia 189 2.9% 2 118
Diarrhoea 180 2.7% 14 82
Eosinophilia 173 2.6% 7 134
Cholestasis 144 2.2% 15 67
Rectal haemorrhage 144 2.2% 21 110
Off label use 137 2.1% 48 87
Subdural haematoma 132 2.0% 55 73

Other Indications for ASPIRIN DL-LYSINE

Product used for unknown indication (1,642) Prophylaxis (705) Thrombosis prophylaxis (468) Myocardial ischaemia (445) Myocardial infarction (186) Cerebrovascular accident (141) Atrial fibrillation (134) Acute coronary syndrome (117) Ischaemic stroke (99) Ischaemic heart disease prophylaxis (84)

Other Drugs Used for Cardiovascular event prophylaxis

ATORVASTATIN (4,792) LIPITOR (1,863) ASPIRIN (950) CANAKINUMAB (560) RIVAROXABAN (432) CLOPIDOGREL BISULFATE (414) TICAGRELOR (351) SEMAGLUTIDE (207) ICOSAPENT ETHYL (196) ROSUVASTATIN (156)

Related Pages

ASPIRIN DL-LYSINE Full Profile All Cardiovascular event prophylaxis Drugs ASPIRIN DL-LYSINE Demographics ASPIRIN DL-LYSINE Timeline